Dr. Lal PathLabs targets up to 20 labs and 800 collection centres in FY26
The diagnostics chain added 18 laboratories and nearly 900 sample collection centres in FY25. Preventive and precision-testing demand is also driving network additions by Agilus Diagnostics, Mahajan Imaging & Labs and Suraksha Clinic and Diagnostics.
The opening
Dr. Lal PathLabs added 18 new laboratories and close to 900 sample collection centres in FY25, and plans 15-20 laboratories plus 700-800 centres in the next calendar year. Agilus, Mahajan Imaging and Suraksha are also expanding diagnostics capacity in India.
Store and format facts
- 18
- close to 900
- 15-20
- 700-800
- FY26
What it means for the format
Dr. Lal PathLabs’ plan to add up to 20 labs and 800 collection centres in FY26 signals sustained network-led growth, making site selection, staffing and sample-logistics execution critical.
Next on the rollout
- Quarterly net additions versus the stated 15-20 labs and 700-800 collection-centre FY26 target.
- Revenue growth, patient volumes, tests per patient and revenue per patient after new-centre openings.
- EBITDA margin movement and collection-centre/lab operating costs, indicating whether expansion is dilutive.
- Turnaround-time metrics, sample rejection rates and any quality or regulatory issues at newly added locations.
- Competitive announcements, pricing actions and network additions from Agilus, Metropolis, Thyrocare, Mahajan and regional chains.
The counter-case
The expansion plan may reflect a defensive race for geographic reach rather than incremental demand. Adding hundreds of collection centres can dilute sample volumes per site, increase partner-management complexity and compress margins through higher logistics, rent and incentive costs. New laboratories are capital-intensive and require utilisation to justify investment; if preventive-testing demand normalises or competition intensifies, the network could become underutilised. The FY26 target is also broadly in line with FY25 additions, so it signals continued rollout rather than an acceleration in growth.